Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Overt Hepatic Encephalopathy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 0 results

Post-approval studies (Phase 4)UnknownNCT03100513
What this trial is testing

PEG (Polyethylene Glycol)Versus Lactulose For Treatment Of Overt Hepatic Encephalopathy

Who this might be right for
Hepatic Encephalopathy
Sherief Abd-Elsalam 100
Testing effectiveness (Phase 2)Study completedNCT01966419
What this trial is testing

Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE)

Who this might be right for
Acute Episode of Overt Hepatic EncephalopathyHepatic Encephalopathy
Ocera Therapeutics, Inc. 231
Not applicableLooking for participantsNCT06483737
What this trial is testing

Human Albumin Infusion in Liver Cirrhosis and Overt Hepatic Encephalopathy (HACHE)

Who this might be right for
Overt Hepatic Encephalopathy
General Hospital of Shenyang Military Region 174
Testing effectiveness (Phase 2)Ended earlyNCT04816916
What this trial is testing

Efficacy and Safety of AXA1665 in Cirrhotic Subjects With Prior Overt Hepatic Encephalopathy

Who this might be right for
Hepatic Encephalopathy
Axcella Health, Inc 12
Post-approval studies (Phase 4)Ended earlyNCT01846663
What this trial is testing

Efficacy, Safety, And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic Encephalopathy

Who this might be right for
Hepatic Encephalopathy
Bausch Health Americas, Inc. 6
Large-scale testing (Phase 3)UnknownNCT02464124
What this trial is testing

Nitazoxanide Plus Lactulose Versus Lactulose Alone Treatment of Hepatic Encephalopathy

Who this might be right for
Encephalopathy, Hepatic
Sherief Abd-Elsalam 120
Not applicableNot Yet RecruitingNCT07634237
What this trial is testing

Personalized Nutritional Intervention in Patients Undergoing TIPS Insertion for Refractory Ascites to Prevent Overt Hepatic Encephalopathy

Who this might be right for
CirrhosisRefractory AscitesTIPS Insertion
McGill University Health Centre/Research Institute of the McGill University Health Centre 50
Not applicableUnknownNCT01097811
What this trial is testing

Comparison Between Erythromycin and Neomycin Treatment of Hepatic Encephalopathy

Who this might be right for
Hepatic EncephalopathyHypertension, PortalLiver Cirrhosis
UPECLIN HC FM Botucatu Unesp 20
Post-approval studies (Phase 4)Study completedNCT07037394
What this trial is testing

A Trial for Comparing Rifaximin, Probiotic and L-ornithine- L Aspartate With Lactulose in Overt Hepatic Encephalopathy.

Who this might be right for
Overt Hepatic Encephalopathy
Qurratul Ain Jamil 252